Pharmacogenomics in cancer

Pharmacogenomics studies how medicine interacts with inherited genes. Here is the latest research on pharmacogenomics in cancer.

December 7, 2021

Exploring the Antiglioma Mechanisms of Luteolin Based on Network Pharmacology and Experimental Verification.

Evidence-based Complementary and Alternative Medicine : ECAM
Renxuan HuangYufei Gao
December 7, 2021

Pharmacogenomic testing and prescribing patterns for patients with cancer in a large national precision medicine cohort.

Journal of Medical Genetics
Jay G Ronquillo, William T Lester
December 6, 2021
Open Access

The Pharmacological Mechanism of Guchangzhixie Capsule Against Experimental Colitis.

Frontiers in Pharmacology
Jing YanZheng Qin
December 6, 2021

Pralsetinib (Gavreto): Treatment of metastatic non-small-cell lung cancer in patients positive for RET fusions.

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Ly Nguyen, Shanada Monestime
December 5, 2021

Pharmacokinetic and pharmacogenomic analysis of low-dose afatinib treatment in elderly patients with EGFR mutation-positive non-small cell lung cancer.

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Hidenori MizugakiAkinobu Hamada
December 4, 2021
Open Access

Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort.

Frontiers in Molecular Biosciences
Yi LiuChenfu Shen
December 3, 2021
Preprint
Open Access

Glucocorticoids Unmask Silent Non-Coding Genetic Risk Variants for Common Diseases

BioRxiv : the Preprint Server for Biology
T. T. L. NguyenRichard M. Weinshilboum
December 3, 2021

A Transcription Factor-Based Risk Model for Predicting the Prognosis of Prostate Cancer and Potential Therapeutic Drugs.

Evidence-based Complementary and Alternative Medicine : ECAM
Ruixiang LuoYinhuai Wang
December 2, 2021

PharmacoDB 2.0: improving scalability and transparency of in vitro pharmacogenomics analysis.

Nucleic Acids Research
Nikta FeiziBenjamin Haibe-Kains
December 2, 2021
Review

Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma.

Cancer Management and Research
Jiaxin Xiao, Xiusheng He
November 29, 2021
Open Access

To explore immune synergistic function of Quercetin in inhibiting breast cancer cells.

Cancer Cell International
Dan QiuMin Ma

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Artificial Chromosomes

Artificial chromosomes are genetically engineered chromosomes derived from the DNA of a species. Discover the latest research on artificial chromosomes here.

Biodiversity Data

Biodiversity refers to the variety and variability of life on Earth. Biodiversity is typically a measure of variation at the genetic, species, and ecosystem level.Discover the latest research on biodiversity data here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

CRISPR & Single Cell Analyses

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on CRISPR-Cas applications relevant to single cell analyses. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

© 2021 Meta ULC. All rights reserved
/feed-previews/pharmacogenomics-in-cancer/3d4ce0ec-d1af-475d-8344-562343316c3b